FybrosenaqTM:Anti-CF QMMMIDD small molecules - Grigoriadis, Ioannis
57,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
29 °P sammeln
  • Broschiertes Buch

Ab initio Systematic Parameterization of Polarizable Force10/1/2019e Field Quantum Chemistry mechanics-based free energy perturbation methodologies for calculating a comparative docking analysis between the FybrosenaqTM QMMMIDD small molecules and the Symkevi compounds (Ivacaftor plus Tezafactor) within the Cystic fibrosis transmembrane conductance Solution structures of peptides based on the Phe508 region, the most common site of disease-causing Delta-F508 mutation: An AMBER-compatible algebraic Superselected Computational Lindenbaum-Tarski in a purely algebraic calculation as a 3D logical Quantum Walk Space in practice.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Ab initio Systematic Parameterization of Polarizable Force10/1/2019e Field Quantum Chemistry mechanics-based free energy perturbation methodologies for calculating a comparative docking analysis between the FybrosenaqTM QMMMIDD small molecules and the Symkevi compounds (Ivacaftor plus Tezafactor) within the Cystic fibrosis transmembrane conductance Solution structures of peptides based on the Phe508 region, the most common site of disease-causing Delta-F508 mutation: An AMBER-compatible algebraic Superselected Computational Lindenbaum-Tarski in a purely algebraic calculation as a 3D logical Quantum Walk Space in practice.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Grigoriadis G. Ioannis has completed his PharmacistD at the age of 24 years from the Aristotle University of Thessaloniki School of Pharmacy. He has published more than 379 papers and He is the Chairman of the WAMS International Board for Pharmaceutical Biotechnology and Clinical Pharmacy and the scientific director of Biogenea Pharm.